6533b857fe1ef96bd12b4481

RESEARCH PRODUCT

Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY model

Miguel Martínez LacalzadaAdrián Viteri NoëlLuis Manzano EspinosaMartin FabregateManuel Rubio RivasSara Luis GarcíaFrancisco Arnalich FernándezJosé Luis Beato PérezJuan Antonio Vargas NúñezElpidio Calvo ManuelAlexia Constanza Espiño ÁLvarezSantiago J. Freire CastroJose Loureiro-amigoPaula Maria Pesqueira FontanAdela PinaAna María ÁLvarez SuárezAndrea Silva AsiainBeatriz García LópezJairo Luque Del PinoJaime Sanz CánovasPaloma Chazarra PérezGema María García GarcíaJesús Millán Núñez CortésJosé Manuel Casas RojoRicardo Gómez HuelgasLuis F. Abrego VacaAna Andreu ArnanzOctavio A. Arce GarcíaMarta Bajo GonzálezPablo Borque SanzAlberto Cózar LlistóBeatriz Del Hoyo CuendaAlejandra Gamboa OsorioIsabel García SánchezÓScar A. López CisnerosBorja Merino OrtizElisa Riera GonzálezJimena Rey GarcíaCristina Sánchez DíazGrisell Starita FajardoCecilia Suárez CarantoñaSvetlana Zhilina ZhilinaSemi-covid-19 Network

subject

Microbiology (medical)medicine.medical_specialtyEvidence-based medicinePrognostic modelsReferralMedicinaCritical IllnessLogistic regressionInitial assessmentRisk Assessmentlaw.inventionlawmedicineHumansMedical historyGeneralizability theoryHospital MortalityRetrospective Studiesbusiness.industryMedicina basada en l'evidènciaCOVID-19Easily obtained clinical variablesGeneral MedicineModels Theoreticalmedicine.diseaseIntensive care unitConfidence intervalHospitalizationInfectious DiseasesSpainEmergency medicineCohortCritical illnessbusinessKidney disease

description

Objectives: We aimed to develop and validate a prediction model, based on clinical history and examination findings on initial diagnosis of coronavirus disease 2019 (COVID-19), to identify patients at risk of critical outcomes. Methods: We used data from the SEMI-COVID-19 Registry, a cohort of consecutive patients hospitalized for COVID-19 from 132 centres in Spain (23rd March to 21st May 2020). For the development cohort, tertiary referral hospitals were selected, while the validation cohort included smaller hospitals. The primary outcome was a composite of in-hospital death, mechanical ventilation, or admission to intensive care unit. Clinical signs and symptoms, demographics, and medical history ascertained at presentation were screened using least absolute shrinkage and selection operator, and logistic regression was used to construct the predictive model. Results: There were 10 433 patients, 7850 in the development cohort (primary outcome 25.1%, 1967/7850) and 2583 in the validation cohort (outcome 27.0%, 698/2583). The PRIORITY model included: age, dependency, cardiovascular disease, chronic kidney disease, dyspnoea, tachypnoea, confusion, systolic blood pressure, and SpO2 ≤93% or oxygen requirement. The model showed high discrimination for critical illness in both the development (C-statistic 0.823; 95% confidence interval (CI) 0.813, 0.834) and validation (C-statistic 0.794; 95%CI 0.775, 0.813) cohorts. A freely available web-based calculator was developed based on this model (https://www.evidencio.com/models/show/2344). Conclusions: The PRIORITY model, based on easily obtained clinical information, had good discrimination and generalizability for identifying COVID-19 patients at risk of critical outcomes.

10.1016/j.cmi.2021.07.006http://hdl.handle.net/2445/181831